Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Contacts and Locations - ClinicalTrials.gov

ClinicalTrials.gov

Home

Search


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00316849

Locations


United States, Arizona
	Mayo Clinic Scottsdale			Recruiting
	Scottsdale, Arizona, United States, 85259-5499
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

United States, Florida
	Mayo Clinic - Jacksonville			Recruiting
	Jacksonville, Florida, United States, 32224
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

United States, Minnesota
	Mayo Clinic Cancer Center			Recruiting
	Rochester, Minnesota, United States, 55905
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

Sponsors and Collaborators

North Central Cancer Treatment Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Jann N. Sarkaria, MD	Mayo Clinic

Investigator:	Evanthia Galanis, MD	Mayo Clinic

Investigator:	John Fiveash, MD	Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham

Investigator:	Jan C. Buckner, MD	Mayo Clinic

Investigator:	Paul D. Brown, MD	Mayo Clinic

Investigator:	Joon H. Uhm, MD	Mayo Clinic

Investigator:	Kurt A. Jaeckle, MD	Mayo Clinic

Investigator:	Bradley J. Erickson, MD, PhD	Mayo Clinic